default author photo

Kifayathullah Liakath-Ali

King’s College London - Centre for Stem Cells and Regenerative Medicine

SCHOLARLY PAPERS

1

DOWNLOADS

26

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

LYVE-1 + Macrophages Form a Collaborative CCR5-Dependent Perivascular Niche That Influences Chemotherapy Responses in Cancer

Number of pages: 61 Posted: 07 Jul 2022
King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - Centre for Stem Cells and Regenerative Medicine, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - Guy’s Cancer Centre, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, The University of Hong Kong - School of Biomedical Sciences, University of Cambridge - Cancer Research UK Cambridge Institute, King’s College London - Centre for Stem Cells and Regenerative Medicine, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, King’s College London - School of Cancer and Pharmaceutical Sciences, University of Birmingham, King’s College London - Centre for Inflammation Biology and Cancer Immunology and King’s College London - School of Cancer and Pharmaceutical Sciences
Downloads 26 (1,372,601)

Abstract:

Loading...

Tumor, macrophage, TAM subset development, perivascular niche, spatial, CCR5, LYVE-1, chemotherapy resistance, immune exclusion